Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Owen

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
European Journal of Gastroenterology & Hepatology|June 16, 2004
Regression of cirrhosis associated with hepatitis B e (HBe) antigen-negative chronic hepatitis B infection with prolonged lamivudine therapyEric M Yoshida, Alnoor Ramji, Nazira Chatur, et al.
The Journal of Rheumatology|February 9, 2008
Granulomatous hepatitis associated with etanercept therapyMyriam Farah, Abdulrahman Al Rashidi, David A Owen, et al.
Digestive Diseases and Sciences|March 26, 2002
Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?Alnoor Ramji, David A Owen, Siegfried R Erb, et al.
The American Journal of Surgical Pathology|August 13, 2011
Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?Sarah L Ondrejka, David F Schaeffer, Maureen A Jakubowski, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 20, 2007
Selective synthesis and reactivity of eta5-arylcyclohexadienyliron complexesDavid A Owen, Andrei V Malkov, Ian M Palotai, et al.
Cases Journal|January 12, 2010
A rare case of isolated duodenal metastases from hepatocellular carcinoma associated with p53 and ki-67 expression: a case reportCaroline Chung, Jaber Al Ali, David A Owen, et al.
The Journal of Pathology|May 14, 2004
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screeningFátima Carneiro, David G Huntsman, Thomas C Smyrk, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonistsDaniel R Allen, Amanda Bolt, Gayle A Chapman, et al.
Anticancer Research|January 25, 2008
Expression of integrin-linked kinase is not a useful prognostic marker in resected hepatocellular cancerPongphob Intaraprasong, Kiran Assi, David A Owen, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
A novel series of potent and selective IKK2 inhibitorsAlistair H Bingham, Richard J Davenport, Lewis Gowers, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
European Journal of Gastroenterology & Hepatology|June 16, 2004
Regression of cirrhosis associated with hepatitis B e (HBe) antigen-negative chronic hepatitis B infection with prolonged lamivudine therapyEric M Yoshida, Alnoor Ramji, Nazira Chatur, et al.
The Journal of Rheumatology|February 9, 2008
Granulomatous hepatitis associated with etanercept therapyMyriam Farah, Abdulrahman Al Rashidi, David A Owen, et al.
Digestive Diseases and Sciences|March 26, 2002
Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance?Alnoor Ramji, David A Owen, Siegfried R Erb, et al.
The American Journal of Surgical Pathology|August 13, 2011
Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?Sarah L Ondrejka, David F Schaeffer, Maureen A Jakubowski, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 20, 2007
Selective synthesis and reactivity of eta5-arylcyclohexadienyliron complexesDavid A Owen, Andrei V Malkov, Ian M Palotai, et al.
Cases Journal|January 12, 2010
A rare case of isolated duodenal metastases from hepatocellular carcinoma associated with p53 and ki-67 expression: a case reportCaroline Chung, Jaber Al Ali, David A Owen, et al.
The Journal of Pathology|May 14, 2004
Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screeningFátima Carneiro, David G Huntsman, Thomas C Smyrk, et al.
Bioorganic & Medicinal Chemistry Letters|November 14, 2006
Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonistsDaniel R Allen, Amanda Bolt, Gayle A Chapman, et al.
Anticancer Research|January 25, 2008
Expression of integrin-linked kinase is not a useful prognostic marker in resected hepatocellular cancerPongphob Intaraprasong, Kiran Assi, David A Owen, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
A novel series of potent and selective IKK2 inhibitorsAlistair H Bingham, Richard J Davenport, Lewis Gowers, et al.
Pageof 4